blood-thinning drug heparin

WASHINGTON: A Chinese factory that has not been inspected by the Food and Drug Administration is the source for the active ingredient of a critical blood-thinning drug whose production was suspended this week after 350 patients reported ill effects from it. At least four people died after being given the drug, heparin.